Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > Million Dollar Molecule
View:
Post by biggdogg on Oct 24, 2022 9:49am

Million Dollar Molecule

OK, This is massive news, how long will it take for a major to buy these guys out? Fullene is massive news, but to make it out of hydrocarbon exhaust? Wow, they will be 100% carbon neutral. I wonder how long it will take for the market to wake the FU#K UP? Only a loonietune would sell this stock at these levels.
Comment by Finnexas on Oct 24, 2022 10:10am
Huge News
Comment by lscfa on Oct 24, 2022 10:38am
So the LOI from 2020 is dead? https://www.globenewswire.com/en/news-release/2020/05/11/2030943/0/en/Voyageur-Secures-Exclusive-Rights-To-One-Of-The-Worlds-Rarest-Pharmaceutical-Minerals-Creating-A-New-Era-In-Carbon-Based-Drug-Development.html
Comment by biggdogg on Oct 24, 2022 10:56am
Obviously!! LMAO, they started this journey in 2021, and look what they achieved! Amazing!!
Comment by WarrantOfficer on Oct 24, 2022 2:55pm
That turned out not to be true sometime ago. They did not secure exclusive rights, later admitted they never did secure exculsive rights and that the LOI was no longer in force.  IMO it was a fabrication.  If you take a read at the link I supplied below, you will see supposed stockpiles of Francis Creek Material that where pictured in the Resource World Magazine July 2019 edition. How ...more  
Comment by biggdogg on Oct 24, 2022 3:11pm
At last years AGM, they stated the deal was uneconomic, the fact they continue to move the project forward is an accomplishment. I dont think the market even understads what a fullerene is. But I bet the big pharma does. The big aspect of this story is Carbon Nuetral. Does anyone really understand the significance? NON DILUTIVE GOV FINANCING
Comment by Finnexas on Oct 24, 2022 4:38pm
Most people don't have a clue how significant this is. Go research C60 and fullerenes. The health benefits and applications are amazing. It has been so expensive that it has not been able to be utilized in most applications. This will potentially solve that for all uses. People love spouting off with out knowing facts or understand how much work and time it takes tomdo these things. Typical ...more  
Comment by oldtrouf on Oct 24, 2022 3:14pm
The whole company is smoke and mirror imo.  From the fast track FDA approval in 2021 to the promised sales starting in 2021.  There is nothing here. They will dilute you into the stone age and that is the only thing you can count on.  And that is IF anyone is willing to finance this mirage.  
Comment by biggdogg on Oct 24, 2022 6:08pm
Hey Warrant Officer, The founders fired the entire management team and board of directors your talking about, LOL, these guys took over in mid to end 2019. They rebuilt this company and are taking it in the right direction, hit hard with Covid BS lockdowns 2020, and AVL plant delays, pushed the company after fullerene, now look at that result. I expect lots of good things to come. This fullerene ...more  
Comment by WarrantOfficer on Oct 26, 2022 7:51am
biggdogg: 22 Mar 2021 Voyageur PR states: AVL recently completed construction in January 2021, of its modern and state of the art Good Manufacturing Practice ("GMP") pharmaceutical manufacturing facility. AVL received its Drug Establishment Licence (DEL) and have passed the inspection and are in full compliance for manufacturing, testing, distribution, importing API and labelling of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1